CLINICAL TRIALS PROFILE FOR DARINAPARSIN
✉ Email this page to a colleague
Clinical Trials for Darinaparsin
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00303199 ↗ | Study of ZIO-101 in Multiple Myeloma | Completed | Ziopharm | Phase 1/Phase 2 | The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma |
| NCT00421213 ↗ | Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers | Completed | Ziopharm | Phase 2 | The study of safety of a new organic arsenic compound in the treatment of hematological malignancies. |
| NCT00423306 ↗ | A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma | Unknown status | Ziopharm | Phase 2 | The study of safety of a new organic arsenic compound in the treatment of advanced hepatocellular carcinoma |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Darinaparsin
Condition Name
Clinical Trial Locations for Darinaparsin
Trials by Country
Clinical Trial Progress for Darinaparsin
Clinical Trial Phase
Clinical Trial Sponsors for Darinaparsin
Sponsor Name
